Kinetics and Durability of Antibody and T-Cell Responses to SARS-CoV-2 in Children

被引:0
作者
Files, Megan A. [1 ]
Gentles, Lauren [2 ]
Kehoe, Leanne [3 ]
Adler, Amanda [3 ]
Lacombe, Kirsten [3 ]
Dickerson, Jane A. [4 ,5 ]
Greninger, Alexander [4 ]
Waghmare, Alpana [6 ,7 ,8 ]
Fairlie, Tarayn [9 ]
Pringle, Kimberly [9 ]
Midgley, Claire M. [9 ]
Hagen, Melissa Briggs [9 ]
Englund, Janet A. [3 ,6 ,8 ]
Seshadri, Chetan [1 ]
机构
[1] Univ Washington, Sch Med, Dept Med, 750 Republican St,Suite E663, Seattle, WA 98109 USA
[2] Fred Hutchinson Canc Ctr, Div Basic Sci, Seattle, WA USA
[3] Seattle Childrens Res Inst, Div Pediat Infect Dis, MA 7-234,4800 Sand Point Way NE, Seattle, WA 98105 USA
[4] Univ Washington, Sch Med, Dept Lab Med & Pathol, Seattle, WA USA
[5] Seattle Childrens Hosp, Dept Labs, Seattle, WA USA
[6] Fred Hutchinson Canc Ctr, Vaccine & Infect Dis Div, Seattle, WA USA
[7] Seattle Childrens Hosp, Ctr Clin & Translat Res, Seattle, WA USA
[8] Univ Washington, Dept Pediat, Seattle, WA USA
[9] Ctr Dis Control & Prevent, Coronavirus & Other Resp Viruses Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
children; COVID-19; SARS-COV-2 nucleocapsid antibody; SARS-COV-2 spike antibody; T-cell immunity to SARS-CoV-2;
D O I
10.1093/infdis/jiae301
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The kinetics and durability of T-cell responses to SARS-CoV-2 in children are not well characterized. We studied a cohort of children aged 6 months to 20 years with COVID-19 in whom peripheral blood mononuclear cells and sera were archived at approximately 1, 6, and 12 months after symptom onset. Methods. We compared antibody responses (n = 85) and T-cell responses (n = 30) to nucleocapsid (N) and spike (S) glycoprotein over time across 4 age strata: 6 months to 5 years and 5-9, 10-14, and 15-20 years. Results. N-specific antibody responses declined over time, becoming undetectable in 26 (81%) of 32 children by approximately 1 year postinfection. Functional breadth of anti-N CD4+ T-cell responses also declined over time and were positively correlated with N-antibody responses (Pearson r = .31, P = .008). CD4+ T-cell responses to S displayed greater functional breadth than N in unvaccinated children and, with neutralization titers, were stable over time and similar across age strata. Functional profiles of CD4+ T-cell responses against S were not significantly modulated by vaccination. Conclusions. Our data reveal durable age-independent T-cell immunity to SARS-CoV-2 structural proteins in children over time following COVID-19 infection as well as S-antibody responses in comparison with declining antibody responses to N.
引用
收藏
页码:889 / 900
页数:12
相关论文
共 50 条
  • [1] Robust Antibody and T Cell Responses to SARS-CoV-2 in Patients with Antibody Deficiency
    Hannah Kinoshita
    Jessica Durkee-Shock
    Mariah Jensen-Wachspress
    Vaishnavi V. Kankate
    Haili Lang
    Christopher A. Lazarski
    Anjeni Keswani
    Kathleen C. Webber
    Kimberly Montgomery-Recht
    Magdalena Walkiewicz
    Luigi D. Notarangelo
    Peter D. Burbelo
    Ivan Fuss
    Jeffrey I. Cohen
    Catherine M. Bollard
    Michael D. Keller
    Journal of Clinical Immunology, 2021, 41 : 1146 - 1153
  • [2] T-Cell Immune Responses to SARS-CoV-2 Infection and Vaccination
    Notarbartolo, Samuele
    VACCINES, 2024, 12 (10)
  • [3] T-cell responses and therapies against SARS-CoV-2 infection
    Toor, Salman M.
    Saleh, Reem
    Sasidharan Nair, Varun
    Taha, Rowaida Z.
    Elkord, Eyad
    IMMUNOLOGY, 2021, 162 (01) : 30 - 43
  • [4] Robust Antibody and T Cell Responses to SARS-CoV-2 in Patients with Antibody Deficiency
    Kinoshita, Hannah
    Durkee-Shock, Jessica
    Jensen-Wachspress, Mariah
    Kankate, Vaishnavi V.
    Lang, Haili
    Lazarski, Christopher A.
    Keswani, Anjeni
    Webber, Kathleen C.
    Montgomery-Recht, Kimberly
    Walkiewicz, Magdalena
    Notarangelo, Luigi D.
    Burbelo, Peter D.
    Fuss, Ivan
    Cohen, Jeffrey I.
    Bollard, Catherine M.
    Keller, Michael D.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (06) : 1146 - 1153
  • [5] T Cell Responses to SARS-CoV-2
    Sette, Alessandro
    Sidney, John
    Crotty, Shane
    ANNUAL REVIEW OF IMMUNOLOGY, 2023, 41 : 343 - 373
  • [6] Antibody Responses to SARS-CoV-2 in Children With COVID-19
    Han, Mi Seon
    Um, Jihye
    Lee, Eun Joo
    Kim, Kyung Min
    Chang, Sung Hee
    Lee, Hyunju
    Kim, Ye Kyung
    Choi, Youn Young
    Cho, Eun Young
    Kim, Dong Hyun
    Choi, Jae Hong
    Lee, Jina
    Kim, Misuk
    Chung, Ki-Hyun
    Min, Hye Sook
    Choe, Young June
    Lim, Dong-Gyun
    Park, Jun-Sun
    Choi, Eun Hwa
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2022, 11 (06) : 267 - 273
  • [7] Insights into the T-cell response to SARS-CoV-2
    Kadi, Chaimae
    Najimi, Nouhaila
    Zakaria, Menanne
    Youssef, Bakri
    Noureddine, Elmtili
    Fouad, Seghrouchni
    EUROPEAN JOURNAL OF INFLAMMATION, 2023, 21
  • [8] Durability of SARS-CoV-2-Specific T-Cell Responses at 12 Months Postinfection
    Lu, Zhongyan
    Laing, Eric D.
    DaMata, Jarina Pena
    Pohida, Katherine
    Tso, Marana S.
    Samuels, Emily C.
    Epsi, Nusrat J.
    Dorjbal, Batsukh
    Lake, Camille
    Richard, Stephanie A.
    Maves, Ryan C.
    Lindholm, David A.
    Rozman, Julia S.
    English, Caroline
    Huprikar, Nikhil
    Mende, Katrin
    Colombo, Rhonda E.
    Colombo, Christopher J.
    Broder, Christopher C.
    Ganesan, Anuradha
    Lanteri, Charlotte A.
    Agan, Brian K.
    Tribble, David
    Simons, Mark P.
    Dalgard, Clifton L.
    Blair, Paul W.
    Chenoweth, Josh
    Pollett, Simon D.
    Snow, Andrew L.
    Burgess, Timothy H.
    Malloy, Allison M. W.
    JOURNAL OF INFECTIOUS DISEASES, 2021, 224 (12) : 2010 - 2019
  • [9] T-cell responses to SARS-CoV-2 in healthy controls and primary immunodeficiency patients
    Awuah, Arnold
    Zamani, Ava
    Tahami, Fariba
    Davis, Mark
    Grandjean, Louis
    Buckland, Matthew
    Gilmour, Kimberly
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2022, 207 (03) : 336 - 339
  • [10] Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression
    Prendecki, Maria
    Clarke, Candice
    Edwards, Helena
    McIntyre, Stacey
    Mortimer, Paige
    Gleeson, Sarah
    Martin, Paul
    Thomson, Tina
    Randell, Paul
    Shah, Anand
    Singanayagam, Aran
    Lightstone, Liz
    Cox, Alison
    Kelleher, Peter
    Willicombe, Michelle
    McAdoo, Stephen P.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (10) : 1322 - 1329